Why Moderna is still the ultimate stock hedge against any outbreak

Will a hantavirus outbreak offset the regulatory risks weighing on Moderna stock? The path to recovery is far from certain.

A New Hantavirus Vaccine Is in the Works

Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising ...

Still ‘many steps to do’ in creating a hantavirus vaccine, experts say

Four Canadians are isolating across the country after exposure on the hantavirus-hit MV Hondius cruise ship. The outbreak has ...

Hantavirus stirs vaccine skeptics, Moderna questions, prediction conspiracy

Marjorie Taylor Greene and other conservative commentators have claimed that Moderna is developing a hantavirus mRNA vaccine.

No cure, no approved vaccine, no antiviral: Why the Hantavirus threat is raising alarm again | Explained

Several research groups and pharmaceutical companies had already been studying hantaviruses before the MV Hondius outbreak ...
NBC Chicago

Moderna says the FDA will consider its new flu shot after resolving a public dispute

The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of-its-kind shot.
The Boston Globe

Moderna gets a win from the FDA, but political headwinds remain a concern for vaccine makers

The whiplash over a new potential flu vaccine from Moderna, which went from rejected to approved for review in a matter of days, has illustrated a new reality plaguing the Cambridge biotech company ...